These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 23581476)
1. Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions. Fretwell LV; Woolard J Br J Pharmacol; 2013 Jul; 169(6):1279-89. PubMed ID: 23581476 [TBL] [Abstract][Full Text] [Related]
2. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways. Brueggemann LI; Haick JM; Neuburg S; Tate S; Randhawa D; Cribbs LL; Byron KL Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L476-86. PubMed ID: 24441871 [TBL] [Abstract][Full Text] [Related]
3. The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo. Hansen HH; Weikop P; Mikkelsen MD; Rode F; Mikkelsen JD Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):46-51. PubMed ID: 27377794 [TBL] [Abstract][Full Text] [Related]
4. Activation of KCNQ channels located on the skeletal muscle membrane by retigabine and its influence on the maximal muscle force in rat muscle strips. Zagorchev P; Apostolova E; Kokova V; Peychev L Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):439-46. PubMed ID: 26815201 [TBL] [Abstract][Full Text] [Related]
6. Potent KCNQ2/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus. Kalappa BI; Soh H; Duignan KM; Furuya T; Edwards S; Tzingounis AV; Tzounopoulos T J Neurosci; 2015 Jun; 35(23):8829-42. PubMed ID: 26063916 [TBL] [Abstract][Full Text] [Related]
7. Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents. Yeung S; Schwake M; Pucovský V; Greenwood Ia Br J Pharmacol; 2008 Sep; 155(1):62-72. PubMed ID: 18536747 [TBL] [Abstract][Full Text] [Related]
8. Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats. Xu W; Wu Y; Bi Y; Tan L; Gan Y; Wang K Mol Pain; 2010 Aug; 6():49. PubMed ID: 20796319 [TBL] [Abstract][Full Text] [Related]
9. Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury. Wu Z; Li L; Xie F; Du J; Zuo Y; Frost JA; Carlton SM; Walters ET; Yang Q J Neurotrauma; 2017 Mar; 34(6):1260-1270. PubMed ID: 28073317 [TBL] [Abstract][Full Text] [Related]
10. Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm. Mani BK; O'Dowd J; Kumar L; Brueggemann LI; Ross M; Byron KL J Cardiovasc Pharmacol; 2013 Jan; 61(1):51-62. PubMed ID: 23107868 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of Kv7.4 channel activity in primary and secondary hypertension. Jepps TA; Chadha PS; Davis AJ; Harhun MI; Cockerill GW; Olesen SP; Hansen RS; Greenwood IA Circulation; 2011 Aug; 124(5):602-11. PubMed ID: 21747056 [TBL] [Abstract][Full Text] [Related]
12. The novel dual-mechanism Kv7 potassium channel/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener retigabine in the 6-Hz refractory seizure mouse model. Bloms-Funke P; Bankstahl M; Bankstahl J; Kneip C; Schröder W; Löscher W Neuropharmacology; 2022 Feb; 203():108884. PubMed ID: 34785163 [TBL] [Abstract][Full Text] [Related]
13. The Kv7 potassium channel activator retigabine decreases alcohol consumption in rats. Knapp CM; O'Malley M; Datta S; Ciraulo DA Am J Drug Alcohol Abuse; 2014 May; 40(3):244-50. PubMed ID: 24735395 [TBL] [Abstract][Full Text] [Related]
14. The contribution of nitric oxide to cardiovascular status and responses to vasodilators in conscious, hypertensive, transgenic ((mRen-2)27) rats. Gardiner SM; March JE; Kemp PA; Bennett T Br J Pharmacol; 1998 May; 124(2):299-306. PubMed ID: 9641546 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in Kv7 channel function in the cerebral and coronary circulation. Lee S; Yang Y; Tanner MA; Li M; Hill MA Microcirculation; 2015 Feb; 22(2):109-121. PubMed ID: 25476662 [TBL] [Abstract][Full Text] [Related]
16. KCNQ2/3/5 channels in dorsal root ganglion neurons can be therapeutic targets of neuropathic pain in diabetic rats. Yu T; Li L; Liu H; Li H; Liu Z; Li Z Mol Pain; 2018; 14():1744806918793229. PubMed ID: 30027794 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of retigabine, a Kv7 channel activator, on mechanosensitive primary bladder afferent activities and nociceptive behaviors in rats. Aizawa N; Wakamatsu D; Kida J; Otsuki T; Saito Y; Matsuya H; Homma Y; Igawa Y Neurourol Urodyn; 2017 Feb; 36(2):280-285. PubMed ID: 26536146 [TBL] [Abstract][Full Text] [Related]
18. Retigabine diminishes the effects of acetylcholine, adrenaline and adrenergic agonists on the spontaneous activity of guinea pig smooth muscle strips in vitro. Apostolova E; Zagorchev P; Kokova V; Peychev L Auton Neurosci; 2017 Mar; 203():51-57. PubMed ID: 28041987 [TBL] [Abstract][Full Text] [Related]
19. Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain. Li L; Li J; Zuo Y; Dang D; Frost JA; Yang Q J Pain; 2019 May; 20(5):528-539. PubMed ID: 30471428 [TBL] [Abstract][Full Text] [Related]
20. Sequence determinants of subtype-specific actions of KCNQ channel openers. Wang AW; Yang R; Kurata HT J Physiol; 2017 Feb; 595(3):663-676. PubMed ID: 27506413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]